1-(4-(2-(3,4-Dichlorophenyl)acetyl)benzyl)azetidine-3-carboxylic Acid

ID: ALA3741988

PubChem CID: 59451852

Max Phase: Preclinical

Molecular Formula: C19H17Cl2NO3

Molecular Weight: 378.25

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Cc1ccc(Cl)c(Cl)c1)c1ccc(CN2CC(C(=O)O)C2)cc1

Standard InChI:  InChI=1S/C19H17Cl2NO3/c20-16-6-3-13(7-17(16)21)8-18(23)14-4-1-12(2-5-14)9-22-10-15(11-22)19(24)25/h1-7,15H,8-11H2,(H,24,25)

Standard InChI Key:  OBNWXMLSNDBBMG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    2.5951   -3.0039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6522   -4.0166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5879   -5.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5309   -4.0092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5795   -6.5683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5373   -7.1631    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6155   -7.1737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5973   -1.5031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6003    1.4977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6024    2.6977    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990    0.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2003    1.4932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4994    0.7432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7985    1.4932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7985    2.9932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4995    3.7432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2004    2.9933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8378    3.5932    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -8.8377    0.8932    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  1  4  1  0
  5  6  2  0
  5  7  1  0
  3  5  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
 15 16  2  0
 15 17  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 18 23  2  0
 21 24  1  0
 20 25  1  0
 17 18  1  0
 12 15  1  0
  1  8  1  0
M  END

Associated Targets(Human)

S1PR5 Tclin Sphingosine 1-phosphate receptor Edg-8 (813 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.25Molecular Weight (Monoisotopic): 377.0585AlogP: 3.94#Rotatable Bonds: 6
Polar Surface Area: 57.61Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 2.78CX Basic pKa: 7.46CX LogP: 1.33CX LogD: 1.11
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -0.93

References

1. Hobson AD, Harris CM, van der Kam EL, Turner SC, Abibi A, Aguirre AL, Bousquet P, Kebede T, Konopacki DB, Gintant G, Kim Y, Larson K, Maull JW, Moore NS, Shi D, Shrestha A, Tang X, Zhang P, Sarris KK..  (2015)  Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.,  58  (23): [PMID:26509640] [10.1021/acs.jmedchem.5b00928]

Source